Comorbidities among Egyptian systemic lupus erythematosus: The COMOSLE-EGYPT study.
Sherif M GamalAbir MokbelMarwa H NiazyFatema T ElgengehyNora Y ElsaidNermeen A FouadNesreen SobhyMarwa TantawySally Samy MohamedRasha M GhalebEnas A AbdelaleemBassel El-ZorkanyPublished in: Chronic illness (2022)
Patients with SLE suffer from several comorbidities, with an increasing risk with age, longer disease duration, higher SLEDAI at onset, cyclophosphamide intake and cumulative pulse intravenous methylprednisone. Risk of mortality is exponentiated with multiple comorbidities.